Report cover image

Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 11th Edition (2025 to 2030)

Publisher Kalorama Information
Published Mar 18, 2026
Length 145 Pages
SKU # KLI21012435

Description

Molecular point-of-care testing continues to reshape diagnostic workflows by bringing the accuracy of molecular methods closer to the patient. In Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 11th Edition (2025 to 2030), Kalorama Information examines a market that has matured significantly over the past decade while remaining dynamic. Distinctions between true point-of-care and near patient molecular testing are not always clear, but Kalorama defines the core value of mPOC as smaller, portable diagnostic devices that answer workflows with rapid turnaround times that make molecular testing practical in physician offices and other decentralized settings.

What This Report Covers

This report provides a comprehensive assessment of the global molecular point-of-care market, with coverage that includes:
  • Market estimates and forecasts for systems and consumables through 2030
  • Segmentation by region, disease area, and company
  • Analysis of both true molecular point-of-care systems and the broader near patient molecular market
  • Market and product level revenue estimates supported by primary and secondary research
Research inputs include company disclosures, government publications, trade journals, business press, analyst reports, legal filings, and interviews with manufacturers, laboratories, and industry experts. All market values are expressed in current U.S. dollars and reflect base year sales for 2025.

How Kalorama Defines Molecular Point-of-Care

The report distinguishes between two primary market segments:
  • True molecular point-of-care systems, characterized by small footprints, rapid turnaround times, and CLIA waived status or near term waiver potential
  • Near patient molecular systems, which include larger or modular platforms that support moderate or high complexity testing in decentralized settings
Key Applications and Growth Opportunities

Historically, mPOC systems have been most successful in respiratory testing, a trend reinforced by COVID-19. While this segment remains price sensitive and competitive with immunoassays, the report identifies additional growth opportunities.

Recent approvals of rapid PCR and molecular home tests have further expanded the addressable market and reinforced the clinical relevance of mPOC technologies.

Table of Contents

145 Pages
CHAPTER 1: EXECUTIVE SUMMARY
ABOUT KALORAMA INFORMATION
SCOPE AND METHODOLOGY
MPOC MARKET OVERVIEW
Defining True Molecular Point of Care
Defining Near Patient Molecular POC
WHERE IS MOLECULAR POINT-OF-CARE IN 2026?
True mPOC Systems
Table 1-1: Global Molecular Point-of-Care Market, 2025-2030 ($ million)
“Near-Patient” Molecular Systems Market
Table 1-2: Global Near Patient Molecular Systems Market, 2025-2030 ($ million)
mPOC Market Observations and Trends
USAGE OF MOLECULAR POINT-OF-CARE
LEADING MPOC PLATFORMS
Table 1-3: Molecular POC Diagnostic Platforms and Technologies
TRENDS
CHAPTER 2: MOLECULAR POINT-OF-CARE MARKET DEVELOPMENT AND TRENDS
MOLECULAR POC AND COVID-19
Table 2-1: Molecular POC COVID-19 Tests and Regulatory Status
CDC Initial Response, Long Term Situation
COVID-19’s Unique Challenge
BARDA Directs Funding to mPO
REGULATORY DEVELOPMENTS
CONSORTIA, FUNDING, PRIZES
DEALS
Table 2-2: Deals in Molecular Point-of-Care, April 2019-December 2025
ADVANTAGES AND DISADVANTAGES OF MOLECULAR POINT-OF-CARE
Table 2-3: Disadvantages of Molecular Point-of-Care, by Setting [Physician Office Laboratory (POL) / Other Outpatient Settings, Developing and Low-Resource Areas, and Hospital POC]
JUSTIFICATION: THE SENSITIVITY/SPECIFICITY ARGUMENT
NEW SYSTEMS AND MENU EXPANSION
New Systems Introduced, in Development
Combination Tests Changing Market: SARS-CoV-2, Flu A, Flu B, and RSV
STI Continues to Be a Growth Area
DEALS, INVESTMENT IN MPOC SYSTEMS
Roche’s Supply and Manufacturing Agreement with Sapphiros
Cepheid’s Partnership with Oxford Nanopore
Roche Acquires LumiraDx
Thermo Acquires Mesa Biotech
CHINA AS A POC MARKET
COMMON TESTS AND ANALYTES IN POC DIAGNOSTICS
COMPONENT TECHNOLOGIES OF MOLECULAR POINT-OF-CARE DIAGNOSTICS
Microfluidics
Quantitative PCR (qPCR)
Microarrays
Isothermal Amplification
Test Automation
Primers and Probes
Detection
Molecular Diagnostics
Real-Time PCR (qPCR)
Isothermal Amplification Methods
Line Probe Assays
Next-Generation Sequencing
APPLICATIONS AND POTENTIAL APPLICATIONS FOR MOLECULAR POINT-OF-CARE
Major Testing Areas for Molecular POC Diagnostics
Influenza
Reclassification of RIDTs
Hospital-Acquired Infections (HAIs)
Strep A
Respiratory Syncytial Virus (RSV)
Emerging Applications
Zika
Other Respiratory Infections
Group B Streptococcus
Human Papillomavirus
Herpes Simplex Virus
Vaginitis
Tuberculosis
Malaria
Other Tropical and Neglected Diseases
Cancer
EUROPEAN DEVICE REGULATIONS
CHAPTER 3: MPOC MARKET ANALYSIS
MOLECULAR POINT-OF-CARE MARKET ANALYSIS
Table 3-1: Global Molecular Point-of-Care Market, 2025-2030 ($ million)
Figure 3-1: Global Molecular Point-of-Care Market, 2025-2030 ($ million)
Market Assumptions and Conclusions
Regional Shares
Table 3-2: Geographic Breakout of the Molecular Point-of-Care (mPOC) Market, by Region, 2025 ($ million) [APAC, Europe, North America, Rest of World]
Segment Breakout
Figure 3-2: Global True mPOC Market, by Disease Indication, 2025 (%) [Respiratory, Other]
“NEAR PATIENT MOLECULAR” MARKET
Table 3-3: Global Near Patient Molecular Systems Market, 2025-2030 ($ million)
Figure 3-3: Global Near Patient Molecular Systems Market, 2025-2030 ($ million)
Figure 3-4: Global Near Patient mPOC Market Share, by Segment, 2025 (%) [Respiratory/COVID, STI/Women's Health, Other]
Figure 3-5: Global Respiratory Near Patient mPOC Market Share, by Test Type, 2025 (%) [Combo/Syndromic, Single Pathogen]
Market Share Near Patient
Figure 3-6: Near Patient Molecular Testing Market Share, by Vendor, 2025 (%)
CHAPTER 4: COMPANY PROFILES
ABBOTT LABORATORIES
AIDIAN OY
AKONNI BIOSYSTEMS
BINX HEALTH, INC.
BIOCARTIS NV
BIOMÉRIEUX SA
Table 4-1: FilmArray and SpotFire Est. Systems Installed per Quarter, Q4 2018-Q3 2025
Figure 4-1: FilmArray and SpotFire Est. Systems Installed by Quarter, Q4 2018-Q3 2025
Figure 4-2: bioMérieux Molecular Biology Revenues by Quarter, Q1 2016-Q3 2025
CEPHEID (DANAHER)
Molecular Healthcare-Acquired Infection (HAI) Testing
Molecular Sexual Health and Women’s Health Testing
Molecular Critical Infectious Disease Testing
Molecular Oncology/Genetics Testing
CREDO DIAGNOSTICS BIOMEDICAL PTE. LTD.
CURETIS NV (OPGEN)
DIASORIN S.P.A
GENMARK DIAGNOSTICS (ROCHE)
GREINER BIO-ONE GMBH
MERIDIAN BIOSCIENCE, INC. (SD BIOSENSOR)
MESA BIOTECH, INC. (THERMO)
SHERLOCK BIOSCIENCES
QIAGEN NV
QUANTUMDX GROUP
QUIDELORTHO CORPORATION
ROCHE
SEKISUI DIAGNOSTICS LLC

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us